Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Treatment outcomes of patients with HIV and tuberculosis.

Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL.

Am J Respir Crit Care Med. 2007 Jun 1;175(11):1199-206. Epub 2007 Feb 8.

PMID:
17290042
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.

Li J, Munsiff SS, Driver CR, Sackoff J.

Clin Infect Dis. 2005 Jul 1;41(1):83-91. Epub 2005 May 26.

PMID:
15937767
[PubMed - indexed for MEDLINE]
Free Article
3.

Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.

Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A, Jones B, Silva-Trigo C, Zhao Z, Hodge T; Tuberculosis Trials Consortium.

Clin Infect Dis. 2005 May 15;40(10):1481-91. Epub 2005 Apr 14.

PMID:
15844071
[PubMed - indexed for MEDLINE]
Free Article
4.

Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis.

Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, Menzies D.

Clin Infect Dis. 2010 May 1;50(9):1288-99. doi: 10.1086/651686. Review.

PMID:
20353364
[PubMed - indexed for MEDLINE]
Free Article
5.

Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.

Sterling TR, Alwood K, Gachuhi R, Coggin W, Blazes D, Bishai WR, Chaisson RE.

AIDS. 1999 Oct 1;13(14):1899-904.

PMID:
10513648
[PubMed - indexed for MEDLINE]
7.

Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.

Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, Ponnuraja C, Dilip M.

Natl Med J India. 2008 Jan-Feb;21(1):3-8.

PMID:
18472696
[PubMed - indexed for MEDLINE]
8.

Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis.

Narita M, Stambaugh JJ, Hollender ES, Jones D, Pitchenik AE, Ashkin D.

Clin Infect Dis. 2000 May;30(5):779-83. Epub 2000 Apr 28. Erratum in: Clin Infect Dis 2000 Jun;30(6):992.

PMID:
10816148
[PubMed - indexed for MEDLINE]
Free Article
9.

Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.

Nettles RE, Mazo D, Alwood K, Gachuhi R, Maltas G, Wendel K, Cronin W, Hooper N, Bishai W, Sterling TR.

Clin Infect Dis. 2004 Mar 1;38(5):731-6. Epub 2004 Feb 17.

PMID:
14986259
[PubMed - indexed for MEDLINE]
Free Article
10.

Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.

Burman W, Benator D, Vernon A, Khan A, Jones B, Silva C, Lahart C, Weis S, King B, Mangura B, Weiner M, El-Sadr W; Tuberculosis Trials Consortium.

Am J Respir Crit Care Med. 2006 Feb 1;173(3):350-6. Epub 2005 Aug 18.

PMID:
16109981
[PubMed - indexed for MEDLINE]
11.

Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients.

Lopez-Cortes LF, Marin-Niebla A, Lopez-Cortes LE, Villanego I, Rodriguez-Diez M, Pascual-Carrasco R.

Int J Tuberc Lung Dis. 2005 Dec;9(12):1385-90.

PMID:
16466062
[PubMed - indexed for MEDLINE]
12.

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim C, Lak KK, Hak C, Dim B, Sin CI, Sun S, Guillard B, Sar B, Vong S, Fernandez M, Fox L, Delfraissy JF, Goldfeld AE; CAMELIA (ANRS 1295–CIPRA KH001) Study Team.

N Engl J Med. 2011 Oct 20;365(16):1471-81. doi: 10.1056/NEJMoa1013911.

PMID:
22010913
[PubMed - indexed for MEDLINE]
Free Article
14.

Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2002 Mar 15;51(10):214-5.

PMID:
11922192
[PubMed - indexed for MEDLINE]
Free Article
15.

Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.

Boulanger C, Hollender E, Farrell K, Stambaugh JJ, Maasen D, Ashkin D, Symes S, Espinoza LA, Rivero RO, Graham JJ, Peloquin CA.

Clin Infect Dis. 2009 Nov 1;49(9):1305-11. doi: 10.1086/606056.

PMID:
19807276
[PubMed - indexed for MEDLINE]
Free Article
16.

Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir.

Zhang J, Zhu L, Stonier M, Coumbis J, Xu X, Wu Y, Arikan D, Farajallah A, Bertz R.

J Antimicrob Chemother. 2011 Sep;66(9):2075-82. doi: 10.1093/jac/dkr266. Epub 2011 Jun 28.

PMID:
21712242
[PubMed - indexed for MEDLINE]
Free Article
17.

Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa.

Connolly C, Reid A, Davies G, Sturm W, McAdam KP, Wilkinson D.

AIDS. 1999 Aug 20;13(12):1543-7.

PMID:
10465079
[PubMed - indexed for MEDLINE]
18.

Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?

Loeliger A, Suthar AB, Ripin D, Glaziou P, O'Brien M, Renaud-Thery F, Crowley S, Williams B, Ridzon R, Granich R, Gilks C.

Int J Tuberc Lung Dis. 2012 Jan;16(1):6-15. doi: 10.5588/ijtld.10.0626. Epub 2011 Aug 3. Review.

PMID:
21819645
[PubMed - indexed for MEDLINE]
19.

Miliary tuberculosis in human immunodeficiency virus infected patients not on antiretroviral therapy: clinical profile and response to shortcourse chemotherapy.

Swaminathan S, Padmapriyadarsini C, Ponnuraja C, Sumathi CH, Rajasekaran S, Amerandran VA, Reddy M, Deivanayagam CN.

J Postgrad Med. 2007 Oct-Dec;53(4):228-31.

PMID:
18097109
[PubMed - indexed for MEDLINE]
Free Article
20.

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.

Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, Pape JW.

Lancet. 2000 Oct 28;356(9240):1470-4.

PMID:
11081529
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk